You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for AXSOME MALTA LTD. v. ALKEM LABORATORIES LTD. (D.N.J. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in AXSOME MALTA LTD. v. ALKEM LABORATORIES LTD.
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .

Details for AXSOME MALTA LTD. v. ALKEM LABORATORIES LTD. (D.N.J. 2023)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2023-09-13 1 Complaint (“the ’917 patent”), 10,351,517 (“the ’517 patent”), 10,195,151 (“the ’151 patent”), 10,512,609 (“the…715 patent, the ’151 patent, the ’609 patent, the ’597 patent, the ’754 patent, the ’976 patent, the…715 patent, the ’151 patent, the ’609 patent, the ’597 patent, the ’976 patent, the ’779 patent, the…715 patent, the ’151 patent, the ’609 patent, the ’597 patent, the ’754 patent, the ’976 patent, the…715 patent, the ’151 patent, the ’609 patent, the ’597 patent, the ’754 patent, the ’976 patent, the External link to document
2023-11-17 32 Answer to Complaint AND Counterclaim (“the ’917 patent”), 10,351,517 (“the ’517 patent”), 10,195,151 (“the ’151 patent”), 10,512,609…infringed U.S. Patent Nos. 8,440,715 (‘the ’715 patent”), 10,195,151 (“the ’151 patent”), 10,512,609 (… to list U.S. Patent Nos. 8,440,715 (‘the ’715 patent”), 10,195,151 (“the ’151 patent”), 10,512,609…Declaratory Judgment of Noninfringement of U.S. Patent No. 10,195,151) 35. Hetero incorporates …Declaratory Judgment of Invalidity of U.S. Patent No. 10,195,151) 39. Hetero incorporates External link to document
2023-12-22 62 Answer to Counterclaim United States Patent Nos. 8,440,715 (‘the ’715 patent”), 10,195,151 (“the ’151 patent”), 10,512,609 …) to list U.S. Patent Nos. 8,440,715 (‘the ’715 patent”), 10,195,151 (“the ’151 patent”), 10,512,609 …’715 patent, the ’151 patent, the ’609 patent, the ’597 patent, the ’754 patent, the ’976 patent, the…the ’779 patent, the ’133 patent, the ’354 patent, and the ’232 patent. ANSWER: Axsome admits …10,512,609 (“the ’609 patent”), 11,439,597 (“the ’597 patent”), 10,912,754 (“the ’754 patent”), 10,959,976 (“ External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.